The California Healthcare Institute said this week that it has elected Daniel O’Day and Michael Onuscheck to its board of directors.
O’Day is currently president and CEO at Roche Molecular Diagnostics in Pleasanton, Calif. Onuscheck is president of the neuromodulation division at Boston Scientific.
CHI is a non-profit public-policy research organization representing California’s academic institutions, and biotechnology, medical device, diagnostics, and pharmaceutical firms.
Arboretum Ventures, headquartered in Ann Arbor, Mich., said this week that it has opened an office at the BioEnterprise facility in Cleveland, and named Jon Snyder manager.
Snyder is joining Arboretum as a venture partner from BioEnterprise, where he was worked since January as CEO in residence.
Arboretum Ventures is an early-stage venture capital firm focusing on investments in medical technology and healthcare services.